Molecular imaging and molecular diagnostics: two sides of the same coin? Marcus HackerGregor HoermannLukas Kenner Editorial 02 June 2018 Pages: 1645 - 1648
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions Margarita KirienkoLuca CozziMartina Sollini Original Article 06 April 2018 Pages: 1649 - 1660
Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST – multicenter study in Japan Kazuhiro KitajimaKoya NakataniYasuo Miyoshi Original Article 12 May 2018 Pages: 1661 - 1671
Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma Pierre DecazesStéphanie BeckerIsabelle Gardin Original Article 28 April 2018 Pages: 1672 - 1679
Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study Mariarosaria IncoronatoAnna Maria GrimaldiMarco Salvatore Original Article 25 April 2018 Pages: 1680 - 1693
Prognostic value of [18F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation Antje StolzenburgKatharina LückerathConstantin Lapa Original Article 02 April 2018 Pages: 1694 - 1704
Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma Yassine Al TabaaEmmanuelle TchernonogGuillaume Cartron Short Communication 20 April 2018 Pages: 1705 - 1709
Diagnostic performance and impact on patient management of 68Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours Marie PaquetMathieu GauthéFrançoise Montravers Original Article 12 March 2018 Pages: 1710 - 1720
Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies Bruno SangroCarlo Ludovico Mainion behalf of the European Network on Radioembolization with Yttrium-90 resin microspheres (ENRY) Original Article Open access 07 March 2018 Pages: 1721 - 1730
A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy Vincent ManceauXavier PalardEtienne Garin Original Article 20 March 2018 Pages: 1731 - 1741
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT Lucas GoenseJelle P. RuurdaSteven H. Lin Original Article Open access 16 April 2018 Pages: 1742 - 1751
Increased evidence for the prognostic value of FDG uptake on late-treatment PET in non-tumour-affected oesophagus in irradiated patients with oesophageal carcinoma Yimin LiFrank HofheinzSebastian Zschaeck Original Article 21 April 2018 Pages: 1752 - 1761
18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients Mohsen BeheshtiLukas HehenwarterChristian Pirich Original Article Open access 08 March 2018 Pages: 1762 - 1771
Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT Serena GrimaldiJacques YoungDésirée Deandreis Original Article 22 April 2018 Pages: 1772 - 1780
Highlights of the 30th Annual Congress of the EANM, Vienna 2017: “Yes we can – make nuclear medicine great again” Stefano FantiRachele BonfiglioliClemens Decristoforo Review Article Open access 03 May 2018 Pages: 1781 - 1794
Recommendations on nuclear and multimodality imaging in IE and CIED infections Paola Anna ErbaPatrizio LancellottiGilbert Habib Guidelines 24 May 2018 Pages: 1795 - 1815
Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline A. SignoreF. JamarE. Lazzeri Guidelines Open access 31 May 2018 Pages: 1816 - 1831
Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory? Eric LaffonRoger Marthan Letter to the Editor 17 May 2018 Pages: 1832 - 1833
Reply to the letter Hajira IlyasN. George MikhaeelSally F. Barrington Reply 31 May 2018 Pages: 1834 - 1835
Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS Ashwin Singh PariharAshwani SoodBhagwant Rai Mittal Image of the Month 01 May 2018 Pages: 1836 - 1837
Correction to: Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma Pierre DecazesStéphanie BeckerIsabelle Gardin Correction 26 May 2018 Pages: 1838 - 1839
